Exploring Relationships Between In Vitro Aqueous Solubility and Permeability and In Vivo Fraction Absorbed

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Introduction

Solubility/dissolution and permeability are essential determinants of gastrointestinal absorption of drugs. In vitro aqueous solubility (S) and apparent permeability (P app ) are commonly used as measurements and predictors of in vivo fraction absorbed (f a ) and BCS-classing in humans. The objective of this study was to explore the relationships between in vitro aqueous S and Dose number (D o ) and in vivo f a and in vitro P app and in vivo f a and the predictive power of in vitro aqueous S, D o and P app .

Methods

In vitro and in vivo data were taken from studies in the literature and correlated. In vitro S data were produced in various laboratories and with different methodologies. In vitro P app data were produced using Caco-2 and MDCK cells in various laboratories and Caco-2 and RRCK cells in one laboratory each. D o was estimated as oral dose / (S • 250 mL).

Results

452 S data and 1480 P app data were found and used. There was no correlation (R 2 =0.0) between in vitro log S and D o vs in vivo f a , not even at S<1 mg/L or not for compounds with <90 % and <30 % in vivo f a . A R 2 of 0.43 was found between log Caco-2 P app and in vivo f a . The corresponding R 2 for Caco-2 from one laboratory was 0.65. The interlaboratory R 2 for the Caco-2 model was 0.48. R 2 -estimates for Caco-2 vs MDCK and Caco-2 vs RRCK P app were 0.23 and 0.21, respectively.

Discussion and Conclusion

Aqueous S appears to have no predictive value of in vivo f a in humans, not even at low S or after correction for dose. The shows that one should not base human biopharmaceutical predictions based on aqueous S. Log Caco-2 P app explains about half of the variance of in vivo f a in humans. The poor correlations found between Caco-2 and the two other P app -models (MDCK and RRCK) demonstrate considerable methodological differences. The unexplained variance does not appear to be explained by S and dose, but rather by in vitro-in vivo difference in permeability and poor/absent relationship between in vitro S and in vivo dissolution potential.

Article activity feed